David Oakley, AdventHealth’s chief digital officer, said AI could transform healthcare personalization — moving from broad population segments to individualized “segments of one.” In the future, providers could use connected data platforms to better understand patients’ clinical, social and emotional needs, which has potential to strengthen both trust and engagement, he stated. The post AI…
Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial endpoint data. Analysts see Clario’s offerings as highly complementary to PPD, the contract research organization that Thermo Fisher acquired in 2021. The post Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario appeared first…
In the shift from isolated expertise to collective insights, shared data are revolutionizing patient care in EMS and hospitals. The post From Silos to Synthesis: How the Information Renaissance is Transforming Emergency Medicine appeared first on MedCity News.
Without clear goals and shared accountability, AI pilots can quickly become exercises in hope rather than strategy. The post ‘Free’ AI Pilots Are Costing Health Systems Millions appeared first on MedCity News.
Eli Lilly’s LillyDirect platform is partnering with Walmart to let patients pick up prescriptions for its GLP-1 drug Zepbound at Walmart pharmacies, expanding access beyond home delivery. The post LillyDirect Taps Walmart for First Retail Pick-Up Option for Zepbound appeared first on MedCity News.
October has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Eli Lilly, CommonSpirit Health and HLM Venture Partners welcomed new executives. There were also layoffs at organizations including Genentech and Jefferson Health. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity…
The FDA clinical hold covers two Phase 3 studies for nexiguran ziclumeran, or nex-z, an experimental gene-editing therapy for transthyretin amyloidosis. Nex-z uses the CRISPR gene-editing technology to inactivate the gene that codes for the protein driving this rare disease. The post Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a…
We must work together across the care continuum to establish both local and network-trusted identity data management capabilities that can unify patient data across fragmented data silos at both the database layer and the front-end digital and physical access layer. The post Creating Exceptional Patient Experiences Starts with Identity Intelligence appeared first on MedCity News.
It’s not the flashiest technologies or rapid-speed AI breakthroughs that can do it. It’s the technologies laser-focused on the unglamorous but all-consuming coordination problems that suck up medical staff’s time, stress them out, and compromise patient care. The post Innovation Fatigue is Rampant: What’s the Rx to Fix It? appeared first on MedCity News.
[Sponsored] The 2025 Benefits Sentiment Index is based on a survey of 120 benefit consultants to self-insured employers and is sponsored by Quantum Health. The post Report Finds Healthcare Navigation Is at a Crossroads appeared first on MedCity News.